Monitoring the evolution of the SARS-CoV-2 virus
Official title: ACTIV TRACE support at NCBI for SARS-CoV-2
Funded at A-Tek, INC. · NIH-10936614 · Data updated 2026-11-12
This study is looking at how the COVID-19 virus changes over time to find out about new variants, which could help improve treatments and vaccines for everyone affected by the virus.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | A-Tek, INC. NIH-funded |
| Lab location | 1 site (Mclean, United States) |
| Project start | September 28, 2023 |
| Project end | September 27, 2028 |
| Funding year | 2023 |
| Award (this year) | $2,354,179 |
| NIH project number | 75N97023F00096-0-0-2 |
| Project ID | NIH-10936614 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include individuals who have been infected with COVID-19 or are at risk of infection, particularly those in areas with high transmission rates.
✕Less likely to help
Patients who have not been infected with COVID-19 or those who are not at risk of exposure may not receive direct benefits from this research.
What this research studies
This research focuses on tracking the genetic changes in the SARS-CoV-2 virus, which causes COVID-19. By evaluating how the virus evolves, the study aims to identify different variants and understand their potential effects on treatments and vaccines. Patients may benefit from this research as it could lead to improved medical countermeasures against COVID-19 variants. The approach involves genomic analysis and characterization of the virus to inform public health strategies.
Why it matters
Potential benefit: If successful, this research could enhance the effectiveness of vaccines and treatments for COVID-19 by providing insights into viral evolution.
How similar studies have gone: Other research has successfully monitored viral evolution in similar contexts, indicating that this approach is both tested and valuable.
Where this research is happening
-
A-Tek, INC.
Mclean, United States Active
Researchers
- Principal investigator: Freeland, Kathryn — A-Tek, INC.
- Study coordinator: Freeland, Kathryn
Related research
Other NIH-funded projects on the same topics.
-
How COVID-19 infection and genes may influence memory and dementia risk
This study looks at how getting COVID-19 and a person’s genes together affect the chance of developing memory problems and Alzheimer’s disease later in life.
-
Understanding flu and COVID-19 vaccine responses in people and in the lab
Researchers at Stanford explore how flu and COVID-19 vaccines work in people and in lab tests to improve protection for adults.
-
Oral small molecule inhibitors to block SARS-CoV-2 RNA replication
A Stanford-led project tests a pill that could stop SARS-CoV-2 and related viruses from copying their RNA inside infected cells.
-
Outpatient antiviral cocktails to fight SARS-CoV-2 and future RNA viruses
Researchers at Stanford are developing outpatient antiviral cocktails that could be used easily outside the hospital to treat COVID-19 and future RNA virus infections.
-
Inhibitors for SARS-CoV-2 Proteases to Block Viral Replication
A patient-facing program aims to discover and optimize small molecules that block key SARS-CoV-2 enzymes, potentially reducing viral replication.
-
How different COVID-19 vaccines shape immune responses
This project compares immune reactions after mRNA and adenoviral COVID-19 vaccines to learn how long protection lasts and why some people get breakthrough infections or side effects.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.